In the past years cancer treatments have drastically changed, mainly due to the development of immune checkpoint inhibitors capable of immune modulation in vivo, thus providing major clinical benefit in a number of malignancies. Simultaneously, considerable technical refinements have opened new prospects for the development of immune cell-based medicinal products and unprecedented success with…
That year, Hill Day brought about 60 ASCO members to Capitol Hill. This year’s event saw more than 170 members visiting the halls of several…
Getting maximum value from these resources does first require that the specimens submitted to the Bank be of consistently high quality – that they comply…
Nature Medicine – Recent developments in bioengineering and organic chemistry have enabled targeting of the previously ‘undruggable’ KRAS; this review summarizes the successes,…
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will…
A documentary film where the title says it all, except… They are housemates and were diagnosed in the same month.
As with last fall’s group meeting, you can install our meeting app on your smart phone (Android or Apple), or you can simply use the online version in…
Invasive cancers typically evade immune surveillance through profound local and systemic immunosuppression, preventing their elimination or control. Targeting immune interventions to prevent or intercept premalignant…
Pilot studies can answer questions about whether a given trial design is feasible within the bounds of the National Clinical Trials Network and/or the NCI…
In recent years, community sites – specifically within the NCI Community Oncology Research Program (NCORP) – have accounted for about one-half of all SWOG-credited trial…
